🚀 Medial Secures Investment on Shark Tank India - Fueling the Future of Professional Social Networking. 🔥

Startup Showcase

Premium Content

Try our Valuation Calculator →

News on Medial

Grapevine: Aragen Life, Urban Company investors weigh stake sale

VCCircle

VCCircle · 11m ago

Grapevine: Aragen Life, Urban Company investors weigh stake sale

Promoters and investors of Aragen Life Sciences are considering selling a 10% stake in a pre-IPO round, valuing the company at around $1.5 billion. Potential investors, such as Quadria Capital and Novo Nordisk, are reported to be in early talks for a minority stake. Aragen Life Sciences is a contract research organization (CRO) that has received backing from Goldman Sachs.

Related News

Avendus Fund leads Rs 300 Cr investment in Aragen Life Sciences

YourStory

YourStory · 9d ago

Avendus Fund leads Rs 300 Cr investment in Aragen Life Sciences

Avendus Future Leaders Fund III led a Rs 300 crore investment in Aragen Life Sciences, a major Indian CRDMO. Partnered with SBI Life Insurance, the fund acquired a minority stake. Avendus's second investment, following La Renon Healthcare, highlights confidence in India's growing CRDMO sector amid increased global outsourcing. Aragen, backed by investors like Goldman Sachs, aims to enhance its services for global pharma innovations with this funding, strengthening its market position further.

Grapevine: TVS Credit, Avendus, Haldiram, Aragen, Yotta in news

VCCircle

VCCircle · 8m ago

Grapevine: TVS Credit, Avendus, Haldiram, Aragen, Yotta in news

TVS Credit, Avendus, Haldiram, Aragen, and Yotta are making headlines. Reports suggest that an investor is interested in acquiring KKR's stake in Avendus. A US-based private equity firm is leading the bidding for a portion of Haldiram. Contract drugmaker Aragen is bringing on board an investor from Singapore. Additionally, Yotta is also in the news for undisclosed reasons.

Goldman Sachs-backed Aragen Life Sciences weighs IPO, in talks with bankers

VCCircle

VCCircle · 8m ago

Goldman Sachs-backed Aragen Life Sciences weighs IPO, in talks with bankers

Aragen Life Sciences, a drug development and manufacturing company backed by Goldman Sachs, is reportedly considering an initial public offering (IPO) and is engaging in talks with bankers. The company, previously known as GVK Biosciences, has undergone a name change and is assessing the potential of going public. Aragen offers contract drug development and manufacturing services.

Inside Avendus’ strategy to tap India’s next wave of unicorns

Livemint

Livemint · 10d ago

Inside Avendus’ strategy to tap India’s next wave of unicorns

Avendus Future Leaders Fund (FLF) has invested ₹300 crore in Aragen Life Sciences alongside SBI Life Insurance, each contributing ₹150 crore. This marks FLF’s second healthcare investment this year, following a previous stake in La Renon Healthcare. The investment was made from FLF III, reflecting the fund's ongoing interest and commitment to the healthcare sector.

Quadria bets $100 mn on IPO-bound contract drugs manufacturer Aragen

VCCircle

VCCircle · 7m ago

Quadria bets $100 mn on IPO-bound contract drugs manufacturer Aragen

Quadria Capital, a healthcare-focused private equity firm, is investing $100 million in Hyderabad-based Aragen Life Sciences, a contract drug development and manufacturing company. This investment includes a fresh capital infusion and a small component of share sales by existing shareholders. Aragen plans to use the funds to expand its capabilities to meet increasing demand in the US and Europe. The investment is considered a pre-IPO fundraise as Aragen is exploring an initial public offering.

Urban Company’s early backers Steadview, Elevation, Accel to sell partial stake

Livemint

Livemint · 11m ago

Urban Company’s early backers Steadview, Elevation, Accel to sell partial stake

Investors in Urban Company, including Steadview Capital, Elevation Capital, and Accel, are planning to sell their stake in the home services platform. The move is expected to generate a combined liquidity of $100-150 million for the venture capital firms. This secondary sale will occur at a valuation lower than the estimated worth of Urban Company, which is valued at $2.6 billion. The sale is part of a larger restructuring of Urban Company's capitalization table in preparation for its planned public listing within the next year.

Dutch investor Prosus pegs IPO-bound Urban Company’s fair value at $2.4 billion

Economic Times

Economic Times · 2m ago

Dutch investor Prosus pegs IPO-bound Urban Company’s fair value at $2.4 billion

Dutch investor Prosus has valued Urban Company, an at-home services platform, at $2.4 billion. It holds a 6.8% stake in the company, which is preparing for an IPO with a Rs 1,900 crore offering. This involves a primary issue and an offer for sale by early investors. Urban Company, recently valued at $1.8 billion, is among several Prosus-backed Indian startups going public as global investors seek to monetize their long-held tech investments in India.

OrbiMed, UK’s BII weigh exit from healthcare firm, in talks with buyout funds

VCCircle

VCCircle · 1y ago

OrbiMed, UK’s BII weigh exit from healthcare firm, in talks with buyout funds

Private equity firm OrbiMed and British International Investment (BII) are reportedly exploring the sale of their stake in an Indian healthcare company through a secondary route. OrbiMed, a healthcare-focused private equity firm, along with BII, a UK-based development finance institution, are seeking to exit their positions in the company through a potential sale to buyout funds.

Grapevine: Da Milano, EPL, Blackstone, Temasek, SavraGram in news

VCCircle

VCCircle · 9m ago

Grapevine: Da Milano, EPL, Blackstone, Temasek, SavraGram in news

Da Milano Italia, a luxury fashion brand, may see the promoter family explore the sale of their stake in the company. Private equity firm Blackstone is considering an exit from one of its portfolio firms that specializes in specialty packaging. Additionally, Temasek, a Singapore-based investment company, is rumored to be planning to increase its stake in SarvaGram, a rural credit startup. These developments were reported in various media outlets.

Grapevine: Tesla India head quits; BluSmart investors weigh biz revival

VCCircle

VCCircle · 3m ago

Grapevine: Tesla India head quits; BluSmart investors weigh biz revival

Tesla India's country head, Prashanth Menon, has resigned after a nine-year tenure. His departure coincides with Tesla's preparations to introduce electric vehicles in India. Meanwhile, BluSmart's investors are contemplating business revival strategies.

Trackers

Active Indian VC’s

OG Capital Email

With a hands-on approach, OG Capital aims to invest in over 20 promising...

Accel Partners Email

Early and growth-stage investments in disruptive technology companies with...

Early-stage venture capital firm investing in technology startups in India. Focus on...

Access All Trackers

Startup Showcase Winners

June 2025

Helping your parents when you are miles away

The Pit Stop Your Cravings Deserve

The next generation E-commerce platform

Enter Ongoing Startup Showcase

Top Users

Trending News on Medial

The Palantir mafia behind Silicon ...

Elon Musk’s xAI published hundred ...

Nikhil Kamath invests Rs 137.5 Cr ...

Download the medial app to read full posts, comements and news.